Improved mechanical, physical and biological properties of chitosan films using Aloe vera and electrospun PVA nanofibers for wound dressing applications
Source abstract
Abstract
Natural polymers such as chitosan and Aloe vera are widely used in novel wound dressings due to their biocompatibility and biodegradability. A problem associated with these polymers is their poor mechanical behavior. Efforts have been made to improve the mechanical properties by mixing synthetic polymers such as PVA, but the role of chitosan and Aloe vera in the final dressing is dimmed. The techniques are also time-consuming and costly and there is still a need for an acceptable and affordable wound dressing which can be made through easily accessible techniques. A new but very simple method is introduced in this work for incorporating PVA nanofibers with Aloe vera-containing chitosan films. Using this method the levels of Aloe vera and chitosan in the system can be optimized at higher scales while benefiting from PVA best mechanical properties as a composite layer. Higher amounts of Aloe vera and chitosan in the system lead to lower product costs and more biocompability. The biological properties of films were examined through cell cytotoxicity and antibacterial tests and compared with Atomic force microscopy results. Physical and mechanical properties of films containing PVA nanofibers were characterized by water vapor permeability, swelling ratio, and tensile tests. The morphology of fibers before and after applying on the films was also observed by scanning electron microscopy. According to the results, this combination of natural and synthetic polymers has led to an affordable, biocompatible, and flexible film for wound dressing applications.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments · Nanocomposite Films for Food Packaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering, Islamic Azad University, North Tehran Branch, Tehran, Iran
Department of Novel Drug Delivery Systems, Iran Polymer and Petrochemical Institute, Tehran, Iran
Department of Biomedical Engineering, Islamic Azad University, Central Tehran Branch, Tehran, Iran
References (31)
Show source-provided references
1. Mohammadi Y · Iran Polym J · 2007 · 16 · 57
2. 10.1080/03639045.2017.137173810.1080/03639045.2017.1371738 ↗
3. 10.12968/jowc.2015.24.6.24510.12968/jowc.2015.24.6.245 ↗
4. 10.1016/j.carbpol.2013.06.02210.1016/j.carbpol.2013.06.022 ↗
5. 10.1007/BF0168570410.1007/BF01685704 ↗
6. 10.1016/j.ejar.2015.09.00310.1016/j.ejar.2015.09.003 ↗
7. 10.1080/0193269090333360610.1080/01932690903333606 ↗
8. Malek VG · Eur J Exp Biol · 2017 · 7 · 24
9. 10.4066/AMJ.2012.130110.4066/AMJ.2012.1301 ↗
10. Horikoshi T, Ogawa A, Saito T, Hoshiro H, Fischer G, Li V. Properties of Polyvinylalcohol fiber as reinforcing materials for cementitious composites. In: International RILEM workshop on HPFRCC in structural applications , 2006 May 6 (Vol. 147). Paris, France: RILEM Publications SARL.
11. 10.1016/j.carbpol.2013.06.02210.1016/j.carbpol.2013.06.022 ↗
12. 10.1016/j.carbpol.2011.10.02010.1016/j.carbpol.2011.10.020 ↗
13. 10.1021/am401637c10.1021/am401637c ↗
14. Sosiati H, Nur Fatihah W, Rahman N, et al. Characterization of the properties of electrospun blended hybrid poly (vinyl alcohol)_Aloe vera/chitosan nano-emulsion nanofibrous membranes. In: Key engineering materials . Zurich: Trans Tech Publications, 2018, pp. 74–79.10.4028/www.scientific.net/KEM.792.74 ↗
15. Uslu I · Hacettepe J Biol Chem · 2010 · 38 · 19
16. Abdullah NA, Sekak KA, Ahmad MR, et al. Characteristics of electrospun PVA-Aloe vera nanofibres produced via electrospinning. In: Proceedings of the international colloquium in textile engineering, fashion, apparel and design 2014 (ICTEFAD 2014) . Singapore: Springer, 2014, pp. 7–11.10.1007/978-981-287-011-7_2 ↗
17. 10.17146/jsmi.2018.19.4.496510.17146/jsmi.2018.19.4.4965 ↗
18. 10.3109/0363904950902664810.3109/03639049509026648 ↗
19. 10.1016/j.actbio.2013.02.02710.1016/j.actbio.2013.02.027 ↗
20. 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P ↗
21. 10.1002/jbm.a.3021110.1002/jbm.a.30211 ↗
22. 10.1002/jps.2121010.1002/jps.21210 ↗
23. 10.7547/87507315-92-1-2410.7547/87507315-92-1-24 ↗
24. 10.1016/j.msec.2008.09.03810.1016/j.msec.2008.09.038 ↗
25. 10.1016/S0142-9612(03)00361-210.1016/S0142-9612(03)00361-2 ↗
26. 10.1016/0167-7799(94)90018-310.1016/0167-7799(94)90018-3 ↗
27. 10.1016/j.carbpol.2015.11.06110.1016/j.carbpol.2015.11.061 ↗
28. Chung Y · Acta Pharmacol Sin · 2004 · 25 · 932
29. 10.1016/S0043-1354(02)00173-210.1016/S0043-1354(02)00173-2 ↗
30. 10.1016/S0142-9418(02)00118-610.1016/S0142-9418(02)00118-6 ↗
31. 10.1080/22243682.2016.119295810.1080/22243682.2016.1192958 ↗